ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Roche Markets CMV Test in Europe

April 29, 2011

Receipt Dates Clarified For AIDS-Cancers PA

July 4, 1997

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002